Biotricity Inc.

0.50
-0.02 (-4.40%)
At close: Mar 13, 2025, 11:55 AM

Company Description

Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions primarily in the United States.

The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses.

It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components.

The company is based in Redwood City, California.

Biotricity Inc.
Biotricity Inc. logo
Country United States
IPO Date Feb 16, 2018
Industry Medical - Devices
Sector Healthcare
Employees 55
CEO Dr. Waqaas Al-Siddiq Ph.D.

Contact Details

Address:
275 Shoreline Drive
Redwood City, California
United States
Website https://www.biotricity.com

Stock Details

Ticker Symbol BTCY
Exchange NASDAQ
Fiscal Year April - March
Reporting Currency USD
CIK Code 0001630113
CUSIP Number 09074H104
ISIN Number US09074H2031
Employer ID 47-2548273
SIC Code 3841

Key Executives

Name Position
Dr. Waqaas Al-Siddiq Ph.D. Founder, President, Chief Executive Officer & Chairman
S. John Ayanoglou Chief Financial Officer
Amir Ali Chief Development Officer
Amjad Talpur Senior Director of Operations
Dr. Fareeha Siddiqui Executive Vice President of Healthcare Solutions

Latest SEC Filings

Date Type Title
Feb 24, 2025 8-K Current Report
Feb 20, 2025 10-Q/A [Amend] Quarterly Report
Feb 19, 2025 10-Q Quarterly Report
Feb 14, 2025 NT 10-Q Filing
Feb 04, 2025 SCHEDULE 13G/A [Amend] Filing
Nov 20, 2024 8-K Current Report
Nov 14, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Nov 14, 2024 10-Q Quarterly Report
Oct 15, 2024 25-NSE Filing
Aug 19, 2024 10-Q Quarterly Report